Posted inPharmaceutical
Amgen(AMGN) reported $19.99 billion in revenues in the nine months ended September 30,2023 and $19.4 billion in revenues in the nine months end September 30,2022.
Investment advice We reckon that $168 per share is a good buy point. Introduction Amgen(AMGN)operate in six commercial areas: inflammation, oncology/hematology, bone health, cardiovascular (CV) disease, nephrology and neuroscience. …
